Caldecot Centre, King's College Hospital, 15-22 Caldecot Road
London, SE5 9RS, United Kingdom
NCT Number: NCT04478760
This study will find out what the reference intervals are for common blood tests in transgender people taking hormone therapy.
Reference intervals help doctors interpret blood test results. They are expressed as two numbers, and most normal results fall between them. If a results fall outside of them, it may be because of a disease. Some blood tests are also affected by normal difference between people, such as age, sex or ethnicity. For these tests, different reference intervals are given for each group of people. Having accurate reference intervals benefits patients because it allows doctors to identify disease faster.
Transgender people have a gender identity which does not match their sex characteristics at birth. Gender identity is the feeling of being a gender, and sex is the biological aspects of growing up male or female. Transgender people may use hormone therapy to help change their appearance to fit their gender identity. This involves taking either oestrogen or testosterone.
For blood tests which are affected by sex, it is not clear what reference intervals should be used for transgender people who are on hormone therapy. This is because they have a mixture of male and female sex characteristics. Answering this question will allow doctors to identify disease in them faster.
The study will take place at cliniQ, at King's College Hospital, which provides health services to transgender people. It will recruit healthy transgender people who attend the clinic for blood tests to monitor their hormone therapy. Participants will fill out a questionnaire, give a urine sample, then have their appointment as normal. Extra tests will also be performed on their blood sample. The aim is to recruit 240 participants. Participant's tests results will then be used to calculate reference intervals.
The study is funded by Viapath Group LLP.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
London, SE5 9RS, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day
Establish reference intervals for routine chemistry and immunoassay test for transgender people on hormone therapy. Establish separate reference intervals for people on masculinising and feminising therapy if they differ substantially.
Time frame: 1 day
Compare different hormone therapy formulations to establish whether there are clinically significant difference in their effects on reference intervals.
Time frame: 1 day
Compare the reference values for transgender people on hormone therapy with the existing cisgender reference intervals to establish whether they are similar enough for the cisgender reference intervals to be used instead.
King's College Hospital NHS Trust
Other
Reference Intervals for 27 Routine Chemistry and Immunoassay Tests in Transgender Adults on Stable Hormone Therapy
Acronym: TransRIHTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05166083
Gender Dysphoria, Hormone Replacement Therapy
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07675564
Clinical Decision-making, Gender Identity
Santa Maria, Rio Grande do Sul, Brazil
View Trial DetailsNCT05116293
Transgender Persons
Seattle, Washington, United States
View Trial DetailsNCT05469204
Transgender Persons
Seattle, Washington, United States
View Trial Details